Literature DB >> 10147008

Quality-of-life assessment in small cell lung cancer.

P Fayers1.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 10147008     DOI: 10.2165/00019053-199202030-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  43 in total

1.  Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.

Authors:  K S Albain; J J Crowley; R B Livingston
Journal:  Chest       Date:  1991-06       Impact factor: 9.410

Review 2.  Chemotherapy of small cell lung cancer.

Authors:  H H Hansen; P E Kristjansen
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

Review 3.  Psychosocial issues in lung cancer patients (Part 1).

Authors:  J Bernhard; P A Ganz
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

4.  Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

Authors: 
Journal:  Respir Med       Date:  1989-01       Impact factor: 3.415

5.  The specificity of quality-of-life measures among the seriously ill.

Authors:  H P Greenwald
Journal:  Med Care       Date:  1987-07       Impact factor: 2.983

6.  The Nottingham Health Profile: subjective health status and medical consultations.

Authors:  S M Hunt; S P McKenna; J McEwen; J Williams; E Papp
Journal:  Soc Sci Med A       Date:  1981-05

Review 7.  Small cell lung cancer.

Authors:  M C Iannuzzi; C H Scoggin
Journal:  Am Rev Respir Dis       Date:  1986-09

8.  The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer.

Authors:  D F Cella; B Orofiamma; J C Holland; P M Silberfarb; S Tross; M Feldstein; M Perry; L H Maurer; R Comis; E J Orav
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

9.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

10.  Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more
  2 in total

1.  Economic and quality-of-life aspects of treating small cell lung cancer.

Authors:  P Graham; J Boyages
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

2.  A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.

Authors:  N M Bleehen; D J Girling; D Machin; R J Stephens
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.